Emergence of the phosphoinositide 3-kinase-akt- mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial- mesenchymal transition

Cells Tissues Organs

Volumn 193, Issue 1-2, 2010, Pages 8-22

  Lamouille, Samy ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell invasion; Epithelial mesenchymal transition; Metastasis; Smad signaling

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; P21 ACTIVATED KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P85; RAS PROTEIN; RHEB PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUBERIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MOTILITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROSIS; HUMAN; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 78650510746     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320172     Document Type: Article

References (126)

1. Acloque, H., M. S. Adams, K. Fishwick, M. Bronner-Fraser, M. A. Nieto (2009) Epithelialmesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:1438-1449.
2. Aguilera, A., L. S. Aroeira, M. Ramirez-Huesca, M. L. Perez-Lozano, A. Cirugeda, M. A. Bajo, G. Del Peso, A. Valenzuela-Fernandez, J. A. Sanchez-Tomero, M. Lopez-Cabrera, R. Selgas (2005) Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Int J Artif Organs 28:164-169.
3. Akhurst, R. J. (2008) TGF-β signaling in epithelial-mesenchymal transition and invasion and metastasis; in Derynck, R., K. Miyazono (eds) The TGF-β Family. New York, Cold Spring Harbor Laboratory Press, pp 939-964.
4. 1. J Cell Sci 121:1036-1045.
5. Azhar, M., J. Schultz Jel, I. Grupp, G. W. Dorn, 2nd, P. Meneton, D. G. Molin, A. C. Gittenberger-de Groot, T. Doetschman (2003) Transforming growth factor-β in cardiovascular development and function. Cytokine Growth Factor Rev 14:391-407.
6. Bachelder, R. E., S. O. Yoon, C. Franci, A. G. de Herreros, A. M. Mercurio (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168:29-33.
7. Bakin, A. V., C. Rinehart, A. K. Tomlinson, C. L. Arteaga (2002) p38 mitogen-activated protein kinase is required for TGF-β-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115:3193-3206.
8. Bakin, A. V., A. K. Tomlinson, N. A. Bhowmick, H. L. Moses, C. L. Arteaga (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor-β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810.
9. Barrallo-Gimeno, A., M. A. Nieto (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151-3161.
10. Batlle, E., E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, A. Garcia De Herreros (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84-89.
11. 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
12. Bierie, B., H. L. Moses (2006a) TGF-β and cancer. Cytokine Growth Factor Rev 17:29-40.
13. Bierie, B., H. L. Moses (2006b) Tumour microenvironment: TGF-β: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6:506-520.
14. Bonafoux, D., W. C. Lee (2009) Strategies for TGF-β modulation: a review of recent patents. Expert Opin Ther Pat 19:1759-1769.
15. Bracken, C. P., PA. Gregory, N. Kolesnikoff, A. G. Bert, J. Wang, M. F. Shannon, G. J. Goodall (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846-7854.
16. Burk, U., J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, T. Brabletz (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582-589.
17. Cano, A., M. A. Perez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. del Barrio, F. Portillo, M. A. Nieto (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83.
18. Chaudhury, A., G. S. Hussey, P. S. Ray, G. Jin, P. L. Fox, P. H. Howe (2010) TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12:286-293.
19. Cho, H. J., K. E. Baek, S. Saika, M. J. Jeong, J. Yoo (2007) Snail is required for transforming growth factor-β-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 353:337-343.
20. Cho, H. J., J. Yoo (2007) Rho activation is required for transforming growth factor-β-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 31:1225-1230.
21. Comijn, J., G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, F. van Roy (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7:1267-1278.
22. 1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542.
23. Das, F., N. Ghosh-Choudhury, L. Mahimainathan, B. Venkatesan, D. Feliers, D. J. Riley, B. S. Kasinath, G. G. Choudhury (2008) Raptor-rictor axis in TGF-β-induced protein synthesis. Cell Signal 20:409-423.
24. Deckers, M., M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, P. ten Dijke (2006) The tumor suppressor Smad4 is required for transforming growth factor-β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202-2209.
25. Derynck, R., R. J. Akhurst, A. Balmain (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117-129.
26. Derynck, R., Y. E. Zhang (2003) Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 425:577-584.
27. Eger, A., K. Aigner, S. Sonderegger, B. Dampier, S. Oehler, M. Schreiber, G. Berx, A. Cano, H. Beug, R. Foisner (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24:2375-2385.
28. Feng, X. H., R. Derynck (2005) Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21:659-693.
29. Gonzalez, E., T. E. McGraw (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8:2502-2508.
30. Gordon, K. J., K. C. Kirkbride, T. How, GC. Blobe (2009) Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 30:238-248.
31. Grande, M., A. Franzen, J. O. Karlsson, L. E. Ericson, N. E. Heldin, M. Nilsson (2002) Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115:4227-4236.
32. Gregory, P. A., A. G Bert, E. L. Paterson, S. C. Barry, A. Tsykin, G. Farshid, M. A. Vadas, Y. Khew-Goodall, G. J. Goodall (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601.
33. Gressner, A. M., R. Weiskirchen, K. Breitkopf, S. Dooley (2002) Roles of TGF-β in hepatic fibrosis. Front Biosci 7: d793-d807.
34. Guertin, D. A., D. M. Sabatini (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9-22.
35. Guertin, D. A., D. M. Sabatini (2009) The pharmacology of mTOR inhibition. Sci Signal 2: pe24.
36. Guertin, D. A., D. M. Stevens, M. Saitoh, S. Kinkel, K. Crosby, J. H. Sheen, D. J. Mullholland, M. A. Magnuson, H. Wu, D. M. Sabatini (2009) mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15:148-159.
37. Gulati, N., M. Karsy, L. Albert, R. Murali, M. Jhanwar-Uniyal (2009) Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Int J Oncol 35:731-740.
38. 1-mediated epithelialto-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 115:1714-1723.
39. Hay, N., N. Sonenberg (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-1945.
40. Holz, M. K., B. A. Ballif, S. P. Gygi, J. Blenis (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123:569-580.
41. Hoot, K. E., J. Lighthall, G Han, S. L. Lu, A. Li, W. Ju, M. Kulesz-Martin, E. Böttinger, X. J. Wang (2008) Keratinocyte-specific Smad2 ablation results in increased epithelialmesenchymal transition during skin cancer formation and progression. J Clin Invest 118:2722-2732.
42. Huber, M. A., N. Azoitei, B. Baumann, S. Grunert, A. Sommer, H. Pehamberger, N. Kraut, H. Beug, T. Wirth (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114:569-581.
43. Iliopoulos, D., C. Polytarchou, M. Hatziapostolou, F. Kottakis, I. G Maroulakou, K. Struhl, P. N. Tsichlis (2009) MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2: ra62.
44. Irie, H. Y., R. V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, N. Kothari, S. Natesan, J. S. Brugge (2005) Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171:1023-1034.
45. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okada, E. G. Neilson (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350.
46. Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M. A. Ruegg, A. Hall, M. N. Hall (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122-1128.
47. Julien, S., I. Puig, E. Caretti, J. Bonaventure, L. Nelles, F. van Roy, C. Dargemont, A. G. de Herreros, A. Bellacosa, L. Larue (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26:7445-7456.
48. Kalluri, R., E. G. Neilson (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784.
49. Kalluri, R., R. A. Weinberg (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
50. Kang, Y., C. R. Chen, J. Massagué (2003) A selfenabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11:915-926.
51. Kishigami, S., Y Mishina (2005) BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 16:265-278.
52. Klattig, J., C. Englert (2007) The Mullerian duct: recent insights into its development and regression. Sex Dev 1:271-278.
53. Klymkowsky, M. W., P. Savagner (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174:1588-1593.
54. Kondo, M., E. Cubillo, K. Tobiume, T. Shirakihara, N. Fukuda, H. Suzuki, K. Shimizu, K. Takehara, A. Cano, M. Saitoh, K. Miyazono (2004) A role for Id in the regulation of TGF-β-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 11:1092-1101.
55. Kong, W., H. Yang, L. He, J. J. Zhao, D. Coppola, W. S. Dalton, J. Q. Cheng (2008) Micro-RNA-155 is regulated by the transforming growth factor-β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773-6784.
56. Lamouille, S., R. Derynck (2007) Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178:437-451.
57. Laplante, M., D. M. Sabatini (2009) mTOR signaling at a glance. J Cell Sci 122:3589-3594.
58. Larue, L., A. Bellacosa (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3-kinase/AKT pathways. Oncogene 24:7443-7454.
59. Lee, M. K., C. Pardoux, M. C. Hall, P. S. Lee, D. Warburton, J. Qing, S. M. Smith, R. Derynck (2007) TGF-β activates Erk MAP kinase signaling through direct phosphorylation of ShcA. EMBO J 26:3957-3967.
60. Lee, Y. I., Y. J. Kwon, C. K. Joo (2004) Integrinlinked kinase function is required for transforming growth factor-β-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun 316:997-1001.
61. 1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal 18:1270-1278.
62. 1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur J Pharmacol 560:101-109.
63. Liu, L., F. Li, J. A. Cardelli, K. A. Martin, J. Blenis, S. Huang (2006) Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25:7029-7040.
64. Liu, P., H. Cheng, T. M. Roberts, J. J. Zhao (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627-644.
65. Ma, L., M. F. Lu, R. J. Schwartz, J. F. Martin (2005) Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132:5601-5611.
66. Masszi, A., A. Kapus (2011) Smaddening complexity: The role of Smad3 in epithelial-myofibroblast transition. Cells Tissues Organs 193:41-52.
67. McDonald, P. C., A. B. Fielding, S. Dedhar (2008) Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 121:3121-3132.
68. Meindl-Beinker, N. M., S. Dooley (2008) Transforming growth factor-β and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol 23 (suppl 1): S122-S127.
69. Mercado-Pimentel, M. E., R. B. Runyan (2007) Multiple transforming growth factor-β isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 185:146-156.
70. Miettinen, P. J., R. Ebner, A. R. Lopez, R. Derynck (1994) TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127:2021-2036.
71. Miyazono, K (2009) Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 85:314-323.
72. Moreno-Bueno, G., F. Portillo, A. Cano (2008) Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27:6958-6969.
73. Moustakas, A., C. H. Heldin (2005) Non-Smad TGF-β signals. J Cell Sci 118:3573-3584.
74. Moustakas, A., C. H. Heldin (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520.
75. Nakajima, Y., T. Yamagishi, S. Hokari, H. Nakamura (2000) Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-β and bone morphogenetic protein (BMP). Anat Rec 258:119-127.
76. Nawshad, A., D. LaGamba, E. D. Hay (2004) Transforming growth factor-β (TGF-β) signaling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 49:675-689.
77. Nguyen, D. X., J. Massagué (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8:341-352.
78. Oft, M., K. H. Heider, H. Beug (1998) TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243-1252.
79. Ozdamar, B., R. Bose, M. Barrios-Rodiles, H. R. Wang, Y Zhang, J. L. Wrana (2005) Regulation of the polarity protein Par6 by TGF-β receptors controls epithelial cell plasticity. Science 307:1603-1609.
80. Padua, D., J. Massagué (2009) Roles of TGF-β in metastasis. Cell Res 19:89-102.
81. Peinado, H., D. Olmeda, A. Cano (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428.
82. Pellegrin, S., H. Mellor (2007) Actin stress fibres. J Cell Sci 120:3491-3499.
83. 3 during murine palate formation. Dev Biol 141:456-460.
84. Perez-Moreno, M. A., A. Locascio, I. Rodrigo, G. Dhondt, F. Portillo, M. A. Nieto, A. Cano (2001) A new role for E12/E47 in the repression of E-cadherin expression and epithelialmesenchymal transitions. J Biol Chem 276:27424-27431.
85. Perk, J., A. Iavarone, R. Benezra (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5:603-614.
86. Piek, E., A. Moustakas, A. Kurisaki, C. H. Heldin, P. ten Dijke (1999) TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112:4557-4568.
87. Pon, Y. L., HY. Zhou, A. N. Cheung, HY. Ngan, A. S. Wong (2008) p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 68:6524-6532.
88. Portella, G., S. A. Cumming, J. Liddell, W. Cui, H. Ireland, R. J. Akhurst, A. Balmain (1998) Transforming growth factor-β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9:393-404.
89. Qiao, M., J. D. Iglehart, A. B. Pardee (2007) Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res 67:5293-5299.
90. Robert, F., J. Pelletier (2009) Translation initiation: a critical signaling node in cancer. Expert Opin Ther Targets 13:1279-1293.
91. 1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int 70:901-909.
92. Ruzinova, M. B., R. Benezra (2003) Id proteins in development, cell cycle and cancer. Trends Cell Biol 13:410-418.
93. 1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett 580:5385-5391.
94. Sarbassov, D. D., S. M. Ali, D. H. Kim, D. A. Guertin, R. R. Latek, H. Erdjument-Bromage, P. Tempst, D. M. Sabatini (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296-1302.
95. Sarbassov, D. D., D. A. Guertin, S. M. Ali, D. M. Sabatini (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
96. Schmidt, C. R., Y. J. Gi, T. A. Patel, R. J. Coffey, R. D. Beauchamp, A. S. Pearson (2005) E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery 138:306-312.
97. Schnaper, H. W., T. Hayashida, S. C. Hubchak, A. C. Poncelet (2003) TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284: F243-F252.
98. Shi, Y., J. Massagué (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700.
99. Shirakihara, T., M. Saitoh, K. Miyazono (2007) Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol Biol Cell 18:3533-3544.
100. Sorrentino, A., N. Thakur, S. Grimsby, A. Marcusson, V. von Bulow, N. Schuster, S. Zhang, C. H. Heldin, M. Landstrom (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199-1207.
101. Tavares, A. L., M. E. Mercado-Pimentel, R. B. Runyan, G. T. Kitten (2006) TGF-β-mediated RhoA expression is necessary for epithelialmesenchymal transition in the embryonic chick heart. Dev Dyn 235:1589-1598.
102. Theriault, B. L., T. G. Shepherd, M. L. Mujoomdar, MW. Nachtigal (2007) BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28:1153-1162.
103. Thiery, J. P (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746.
104. Thiery, J. P, H. Acloque, RY. Huang, M. A. Nieto (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
105. Thiery, J. P., J. P. Sleeman (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142.
106. Thuault, S., U. Valcourt, M. Petersen, G. Manfioletti, C. H. Heldin, A. Moustakas (2006) Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174:175-183.
107. 1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27:2626-2634.
108. Valcourt, U., M. Kowanetz, H. Niimi, C. H. Heldin, A. Moustakas (2005) TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelialmesenchymal cell transition. Mol Biol Cell 16:1987-2002.
109. Vardouli, L., A. Moustakas, C. Stournaras (2005) LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-β. J Biol Chem 280:11448-11457.
110. Vincent, T., E. P. Neve, J. R. Johnson, A. Kukalev, F. Rojo, J. Albanell, K. Pietras, I. Virtanen, L. Philipson, P. L. Leopold, R. G. Crystal, A. G. de Herreros, A. Moustakas, R. F. Pettersson, J. Fuxe (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition. Nat Cell Biol 11:943-950.
111. Willis, B. C., Z. Borok (2007) TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293: L525-L534.
112. Wu, L., R. Derynck (2009) Essential role of TGF-β signaling in glucose-induced cell hypertrophy. Dev Cell 17:35-48.
113. 1- induced EMT in vitro. Neoplasia 6:603-610.
114. Xu, J., S. Lamouille, R. Derynck (2009) TGF-β-induced epithelial to mesenchymal transition. Cell Res 19:156-172.
115. Yamashita, M., K. Fatyol, C. Jin, X. Wang, Z. Liu, Y. E. Zhang (2008) TRAF6 mediates Smadindependent activation of JNK and p38 by TGF-β. Mol Cell 31:918-924.
116. Yang, J., S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, R. A. Weinberg (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939.
117. 3 integrin up-regulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75:1292-1301.
118. Yi, J. Y., I. Shin, C. L. Arteaga (2005) Type I transforming growth factor-β receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280:10870-10876.
119. Yilmaz, M., G. Christofori (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15-33.
120. Yu, L., M. C. Hebert, Y. E. Zhang (2002) TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 21:3749-3759.
121. Zavadil, J., E. P. Böttinger (2005) TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24:5764-5774.
122. Zeisberg, E. M., O. Tarnavski, M. Zeisberg, A. L. Dorfman, J. R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W. T. Pu, A. B. Roberts, E. G. Neilson, M. H. Sayegh, S. Izumo, R. Kalluri (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961.
123. 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968.
124. Zeisberg, M., E. G. Neilson (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-1437.
125. Zeisberg, M., A. A. Shah, R. Kalluri (2005) Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280:8094-8100.
126. Zhou, B. P., J. Deng, W. Xia, J. Xu, Y. M. Li, M. Gunduz, M. C. Hung (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:93-940.